Literature DB >> 26897357

Tumor Suppressor Candidate 1 Suppresses Cell Growth and Predicts Better Survival in Glioblastoma.

Rui Zhang1,2, Wan Yu3, Guanyu Liang4, Zhanjun Jia1, Zhengxin Chen2, Lin Zhao2, Yongsheng Yuan5, Xiaobin Zhou6, Daqian Li7, Shuying Shen8, Ning Liu2,9, Aihua Zhang4, Huibo Wang10,11, Gang Wang12.   

Abstract

Glioblastoma (GBM) is the most common malignant brain tumor with poor prognosis and limited treatment options. Tumor suppressor candidate 1 (TUSC1) was recently identified as a potential tumor suppressor in human cancers. However, the expression and potential function of TUSC1 in GBM remain unclear. Herein, we report that TUSC1 is significantly decreased in GBM tissues and cell lines. Patients with high levels of TUSC1 displayed a significant better survival compared with those with low levels of TUSC1. Functional experiments demonstrated that exogenous expression of TUSC1 inhibited GBM cell proliferation and induced G1 phase arrest by down-regulating CDK4. Moreover, overexpression of TUSC1 retarded tumor growth in vivo. Together, our findings revealed that TUSC1 might be a crucial tumor suppressor gene and a novel therapeutic target for GBM.

Entities:  

Keywords:  Glioblastoma; Proliferation; TUSC1; Tumor suppressor

Mesh:

Substances:

Year:  2016        PMID: 26897357     DOI: 10.1007/s10571-016-0339-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  12 in total

1.  Medical oncology: treatment and management of malignant gliomas.

Authors:  Deric M Park; Sith Sathornsumetee; Jeremy N Rich
Journal:  Nat Rev Clin Oncol       Date:  2010-02       Impact factor: 66.675

2.  Malignant gliomas in adults.

Authors:  Michael A Meyer
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

3.  MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.

Authors:  Rui Zhang; Hui Luo; Shuai Wang; Wanghao Chen; Zhengxin Chen; Hong-Wei Wang; Yuanyuan Chen; Jingmin Yang; Xiaotian Zhang; Wenting Wu; Shu-Yu Zhang; Shuying Shen; Qingsheng Dong; Yaxuan Zhang; Tao Jiang; Daru Lu; Shiguang Zhao; Yongping You; Ning Liu; Huibo Wang
Journal:  Neuro Oncol       Date:  2014-06-20       Impact factor: 12.300

Review 4.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

5.  Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.

Authors:  Dai Shimizu; Mitsuro Kanda; Shuji Nomoto; Hisaharu Oya; Hideki Takami; Soki Hibino; Masaya Suenaga; Yoshikuni Inokawa; Mitsuhiro Hishida; Nao Takano; Yoko Nishikawa; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Oncol Rep       Date:  2013-12-20       Impact factor: 3.906

Review 6.  Regulators of G1 cyclin-dependent kinases and cancers.

Authors:  Mong-Hong Lee; Heng-Yin Yang
Journal:  Cancer Metastasis Rev       Date:  2003-12       Impact factor: 9.264

7.  Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer.

Authors:  Zhihong Shan; Tracy Parker; Jonathan S Wiest
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

8.  Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.

Authors:  Mitsuro Kanda; Dai Shimizu; Shuji Nomoto; Soki Hibino; Hisaharu Oya; Hideki Takami; Daisuke Kobayashi; Suguru Yamada; Yoshikuni Inokawa; Chie Tanaka; Tsutomu Fujii; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  J Surg Oncol       Date:  2014-04-02       Impact factor: 3.454

Review 9.  G1 cell-cycle control and cancer.

Authors:  Joan Massagué
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo.

Authors:  Zhihong Shan; Abbas Shakoori; Sohrab Bodaghi; Paul Goldsmith; Jen Jin; Jonathan S Wiest
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  5 in total

1.  Frequent homozygous deletions of the CDKN2A locus in somatic cancer tissues.

Authors:  Abdulaziz Hamid; Beniamin Petreaca; Ruben Petreaca
Journal:  Mutat Res       Date:  2019-04-25       Impact factor: 2.433

2.  Association of TUSC1 and DPF3 gene polymorphisms with male infertility.

Authors:  Youichi Sato; Chise Hasegawa; Atsushi Tajima; Shiari Nozawa; Miki Yoshiike; Eitetsue Koh; Jiro Kanaya; Mikio Namiki; Kiyomi Matsumiya; Akira Tsujimura; Kiyoshi Komatsu; Naoki Itoh; Jiro Eguchi; Aiko Yamauchi; Teruaki Iwamoto
Journal:  J Assist Reprod Genet       Date:  2017-10-03       Impact factor: 3.412

3.  miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis.

Authors:  Li-Ya Ji; Ming Wei; Yuan-Yuan Liu; Zheng-Li Di; San-Zhong Li
Journal:  Oncol Rep       Date:  2021-10-19       Impact factor: 3.906

4.  YARG: A repository for arsenic-related genes in yeast.

Authors:  Jagat Rathod; Hao-Ping Tu; Yung-I Chang; Yu-Han Chu; Yan-Yuan Tseng; Jiin-Shuh Jean; Wei-Sheng Wu
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

5.  An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.

Authors:  Zhuotao Zheng; Lingyue Zhang; Zewei Tu; Yan Deng; Xiaolong Yin
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.